BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Career Advice

  Heptares Founder Shares Her Best Life Sciences Career Advice

  Fiona Marshall founded Heptares Therapeutics, which is now one of the leading biotech companies in the UK.

  November 13, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Novartis Showcases 4 Potential Blockbusters in Its Late-Stage Pipeline

  Novartis is not resting on the laurels of having the first-ever-approval for a CAR-T cancer drug, Kymriah.

  November 13, 2017

   · 

  3 min read

   · 

  Alex Keown
• 

  Biotech Bay

  5 Reasons Why Top Scientists Dump Kendall Square for Silicon Valley

  A look at the reasons why top life science talent from Boston’s Kendall Square biotech hub are moving to the San Francisco Bay Area.

  November 13, 2017

   · 

  6 min read

   · 

  Mark Terry
• 

  Drug Development

  San Diego’s Mirati Therapeutics Abandons Lead Drug, Shifts Focus

  Two months after positive preliminary data showed sitravatinib in combination with Opdivo demonstrated some efficacy in treating patients with NSCLC, Mirati said it will reprioritize its R&D to focus.

  November 13, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  BioMidwest

  Medtronic’s Insulin Pump Dominance Boosted by Johnson & Johnson’s Exit

  Good news seems to keep coming for medtech company Medtronic.

  November 13, 2017

   · 

  2 min read

   · 

  Alex Keown
• Deals

  Week in Review: China’s Creat to Restructure $1.5B Biotest Takeover

  Creat Group will attempt to restructure its $1.5M offer to acquire Biotest after U.S. regulators nixed the deal.

  November 13, 2017

   · 

  1 min read
• Drug Development

  Corvus Pharmaceuticals Announces Updated Clinical Data from Phase 1/1b Study of CPI-444 and Biomarker Data for Potential Use in Patient Selection

  Results showed a response rate of 14 percent (two partial responses, one of which was unconfirmed) with single agent CPI-444 and 13 percent (two confirmed partial responses) for the combination therapy.

  November 13, 2017

   · 

  11 min read
• Business

  Punjab Province in Pakistan Signs Agreement With Novartis Access Against Chronic Diseases

  Poor patients in the province of Punjab will soon have free access to high-quality medicines from the Novartis Access portfolio targeting four key noncommunicable disease areas.

  November 13, 2017

   · 

  6 min read
• 

  Drug Development

  Amgen’s New Analyses Show Repatha Significantly Reduced Cardiovascular Events in Patients With Peripheral Artery Disease and in Patients With a History of Heart Attacks

  These results highlight Repatha’s ability to reduce the residual risk for CV events particularly in high-risk patients with limited treatment options.

  November 13, 2017

   · 

  18 min read
• Business

  Synlogic Reports Third Quarter 2017 Financial Results and Recent Progress

  As of September 30, 2017, Synlogic had cash, cash equivalents, and short-term investments of $96.6 million.

  November 13, 2017

   · 

  9 min read